Harvard Bioscience Inc (HBIO)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Harvey Partners

Jeffrey Moskowitz

2,712,700 $11,393,340 -7% 1.4%
2. 1,439,182 $6,044,564 +2% 0.06%
3.
Archon Capital Management

Constantinos J. Christofilis

1,361,769 $5,719,430 1.28%
4. 1,124,206 $4,721,665 -2% 2.68%
5. 1,043,546 $4,382,893 -2% 0.41%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.62 16,192 Director 202,485 2023-03-15 Filing
$2.67 13,808 Director 186,293 2023-03-14 Filing
$2.60 20,000 Officer, Director 2,886,052 2023-03-15 Filing
$2.67 20,000 Officer, Director 2,866,052 2023-03-14 Filing
$2.61 15,000 Officer, Director 2,278,811 2022-12-01 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.02 48,175 Officer, Director 2,091,725 2021-08-23 Filing
$7.14 24,312 Officer, Director 2,279,778 2021-05-21 Filing
$7.03 14,876 Officer, Director 2,279,778 2021-05-20 Filing
$7.17 39,188 Officer, Director 2,279,778 2021-05-19 Filing
$7.41 39,188 Officer, Director 2,279,788 2021-05-18 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 3,408,796 $14,316,943 5.92%
2. 2,947,329 $12,378,782 0.79%
3. 2,053,907 $8,626,409 9.88%
4. 1,745,133 $7,329,650 0%
5. 1,743,996 $7,324,783 0%
News See All